Therefore, comprehending the molecular intricacies governing the regulation of tumor immune escape assumes paramount importance, as it holds profound implications for refining the efficacy of anti-PD-L1/PD-1 therapy and shaping prognostic outcomes. The gene discussed is CD274; the disease is neoplasm.